The DOI matches its Crossref record; 49 of the 52 references it cites were found in a registry or an index.
Development and validation of the Dimensional Anhedonia Rating Scale (DARS) in a community sample and individuals with major depression
Abstract
Anhedonia, a core symptom of Major Depressive Disorder (MDD), is predictive of antidepressant non-response. In contrast to the definition of anhedonia as a "loss of pleasure", neuropsychological studies provide evidence for multiple facets of hedonic function. The aim of the current study was to develop and validate the Dimensional Anhedonia Rating Scale (DARS), a dynamic scale that measures desire, motivation, effort and consummatory pleasure across hedonic domains. Following item selection procedures and reliability testing using data from community participants (N=229) (Study 1), the 17-item scale was validated in an online study with community participants (N=150) (Study 2). The DARS was also validated in unipolar or bipolar depressed patients (n=52) and controls (n=50) (Study 3). Principal components analysis of the 17-item DARS revealed a 4-component structure mapping onto the domains of anhedonia: hobbies, food/drink, social activities, and sensory experience. Reliability of the DARS subscales was high across studies (Cronbach's α=0.75-0.92). The DARS also demonstrated good convergent and divergent validity. Hierarchical regression analysis revealed the DARS showed additional utility over the Snaith-Hamilton Pleasure Scale (SHAPS) in predicting reward function and distinguishing MDD subgroups. These studies provide support for the reliability and validity of the DARS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In patients with MDD/bipolar depressive episodes, the DARS showed excellent internal consistency (Cronbach’s α = 0.96), convergent validity with another anhedonia scale (r = − 0.79), moderate correlation with a depression measure (r = − 0.37), and was able to distinguish MDD from healthy controls [49].”
From Patient-reported outcome measures for life engagement in mental health: a systematic review (2022) · cites this paper as [49]
In the citing paper
“The DARS [49] measures desire/interest, motivation, effort, and pleasure “right now”.”
From Patient-reported outcome measures for life engagement in mental health: a systematic review (2022) · cites this paper as [49]
Citations
Cites
The CES-D Scale: A Self-Report Depression Scale for Research in the General Population
Radloff, L. S. (1977) · Applied Psychological Measurement · doi:10.1177/014662167700100306 · Cited by 53,267
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
Discovering Statistics Using SPSS
Field, A. P., & Miles, J. N. V. (2000) · Medical Entomology and Zoology · Cited by 28,269
(1998) · The Journal of Clinical Psychiatry · Cited by 19,139
Applied Multivariate Statistics for the Social Sciences
Stevens, J. P. (2012) · Routledge eBooks · doi:10.4324/9780203843130 · Cited by 10,652
Costello, A. B., & Osborne, J. (2005) · University of Massachusetts Amherst · doi:10.7275/jyj1-4868 · Cited by 10,297
Carver, C. S., & White, T. L. (1994) · Journal of Personality and Social Psychology · doi:10.1037/0022-3514.67.2.319 · Cited by 7,306
The mini international neuropsychiatric interview
Lecrubier, Y., Sheehan, D. V., Hergueta, T., & Weiller, E. (1998) · European Psychiatry · doi:10.1016/s0924-9338(99)80239-9 · Cited by 5,899
Factor Retention Decisions in Exploratory Factor Analysis: a Tutorial on Parallel Analysis
Hayton, J. C., Allen, D. G., & Scarpello, V. (2004) · Organizational Research Methods · doi:10.1177/1094428104263675 · Cited by 3,104
(2002) · Cited by 2,645
Research works printed but not linked: 1
- Currey, 2002, Five-item rheumatology attitudes index (RAI): disadvantages of a single positively worded item, Arthritis Rheumatol., 46, S239
Cited by
Sorted by citations
Neuroscience of apathy and anhedonia: a transdiagnostic approach
Husain, M., & Roiser, J. P. (2018) · Nature reviews. Neuroscience · doi:10.1038/s41583-018-0029-9 · Cited by 682
Assessing anhedonia in depression: potentials and pitfalls
Rizvi, S. J., Pizzagalli, D. A., Sproule, B. A., & Kennedy, S. H. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.03.004 · Cited by 571
“…Scale (ACIPS) Gooding and Pflum, 2014 17-item, 6 point scale - only measures social anhedonia .86 Healthy controls Dimensional Anhedonia Rating Scale Rizvi et al, 2015 17-item, 5 point scale -evaluates interest, motivation, effort, and pleasure across domains 0.92-0.96 Community sample Healthy…”
BackgroundMethodInfluentialSelf-citationImmune targets for therapeutic development in depression: towards precision medicine
Drevets, W. C., Wittenberg, G. M., Bullmore, E. T., & Manji, H. K. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00368-1 · Cited by 348
Anhedonia is associated with suicidal ideation independently of depression: A meta-analysis
Ducasse, D., Loas, G., Dassa, D., Gramaglia, C. M., Zeppegno, P., Guillaume, S., Olié, É., & Courtet, P. (2017) · Depression and Anxiety · doi:10.1002/da.22709 · Cited by 284
“The recently developed Dimensional Anhedonia Rating Scale could be suitable for this (Rizvi et al., 2015).”
MethodMental imagery as a “motivational amplifier” to promote activities
Renner, F., Murphy, F. C., Ji, J. L., Manly, T., & Holmes, E. A. (2019) · Behaviour Research and Therapy · doi:10.1016/j.brat.2019.02.002 · Cited by 229
Pizzagalli, D. A. (2022) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20220423 · Cited by 214
“To address these limitations, and informed by more modern (neuroscientific) conceptualizations of anhedonia, second-generation scales, such as the Dimensional Anhedonia Rating Scale (128) and the Temporal Experience of Pleasure Scale (129), have been developed to probe different subdomains, including anticipatory vers…”
MethodWang, S., Leri, F., & Rizvi, S. J. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110289 · Cited by 171
Self-citationon behalf of the CAN-BIND Investigator Team, Lam, R. W. M., Milev, R. V., Rotzinger, S., Andreazza, A. C., Blier, P., Brenner, C. A., Daskalakis, Z. J., Dharsee, M., Downar, J. H., et al. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-0785-x · Cited by 152
“We also assessed other behavioural and dimensional constructs, including aversive and incentive motivation (Behavioural Inhibition System/Behavioural Activation System; BIS/BAS) [26], anhedonia (Dimensional Anhedonia Rating Scale; DARS; and Snaith-Hamilton Pleasure Scale; SHAPS) [27, 28], personality (NEO Five-Factor…”
Self-citationWatson, R., Harvey, K., McCabe, C., & Reynolds, S. A. (2019) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-019-01364-y · Cited by 145
“Dimensional Anhedonia Rating Scale; DARS) [23].”
BackgroundPositive affect treatment targets reward sensitivity: A randomized controlled trial.
Craske, M. G., Meuret, A. E., Echiverri-Cohen, A. M., Rosenfield, D., & Ritz, T. (2023) · Journal of Consulting and Clinical Psychology · doi:10.1037/ccp0000805 · Cited by 152
Markov, D. D. (2022) · Brain Sciences · doi:10.3390/brainsci12101287 · Cited by 134
Positive affect and reward processing in the treatment of depression, anxiety and trauma
Craske, M. G., Dunn, B. D., Meuret, A. E., Rizvi, S. J., & Taylor, C. T. (2024) · Nature Reviews Psychology · doi:10.1038/s44159-024-00355-4 · Cited by 110
“Traits of chronically diminished positive affect (clinical anhedonia) were typically assessed via standardized self-report questionnaires, in which the person provided estimates of their interest and joy in general or in relation to pleasurable activities either in the present or over an interval of time (for example,…”
Self-citationAnhedonia in Depressive Disorder: A Narrative Review
Fruyt, J. D., Sabbe, B., & Demyttenaere, K. (2020) · Psychopathology · doi:10.1159/000508773 · Cited by 97
Forbes, C. N. (2020) · Clinical Psychology Review · doi:10.1016/j.cpr.2020.101860 · Cited by 90
Katzman, M., & Sternat, T. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s111818 · Cited by 83
“Of these, the Dimensional Anhedonia Rating Scale has the best reliability and validity.(93) However, currently available assessments evaluate the current state of hedonic tone and do not take into account its long-term aspects.”
The Positive Valence Systems Scale: Development and Validation
Khazanov, G. K., Ruscio, A. M., & Forbes, C. N. (2019) · Assessment · doi:10.1177/1073191119869836 · Cited by 83
“Although the authors did not compare the types of activities nominated by depressed versus nondepressed individuals, they noted that participants commonly expressed difficulty coming up with rewards to rate (Rizvi et al., 2015).”
InfluentialPictet, A., Jermann, F., & Ceschi, G. (2016) · Behaviour Research and Therapy · doi:10.1016/j.brat.2016.07.008 · Cited by 79
Anhedonia as a transdiagnostic symptom across psychological disorders: a network approach
Guineau, M. G., Ikani, N., Rinck, M., Collard, R. M., van Eijndhoven, P., Tendolkar, I., Schene, A. H., Becker, E. S., & Vrijsen, J. N. (2022) · Psychological Medicine · doi:10.1017/s0033291722000575 · Cited by 83
“Hence, our results should be interpreted with caution and replication of these findings with validated anhedonia measures, such as the SHAPS (Snaith et al., 1995) or DARS (Rizvi et al., 2015) is warranted.”
Progress and challenges in research of the mechanisms of anhedonia in major depressive disorder
Su, Y., & Si, T. (2022) · General Psychiatry · doi:10.1136/gpsych-2021-100724 · Cited by 76
Anhedonia as a Key Clinical Feature in the Maintenance and Treatment of Opioid Use Disorder
Kiluk, B. D., Yip, S. W., DeVito, E. E., Carroll, K. M., & Sofuoglu, M. (2019) · Clinical Psychological Science · doi:10.1177/2167702619855659 · Cited by 61
“Other, more recently developed self-report measures that take into account different facets of reward function beyond consummatory pleasure include the Motivation and Pleasure Scale–Self-Report (MAP-SR; Llerena et al., 2013), the Specific Loss of Interest Scale (SLIPS; Winer, Veilleux, & Ginger, 2014), the Anticipator…”
BackgroundDunlop, K., Rizvi, S. J., Kennedy, S. H., Hassel, S., Strother, S. C., Harris, J. K., Zamyadi, M., Arnott, S. R., Davis, A. D., Mansouri, F., et al. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0688-x · Cited by 63
Self-citationThe characteristics of anhedonia in depression: a review from a clinically oriented perspective
Wu, C., Mu, Q., Gao, W., & Lu, S. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03310-w · Cited by 71
“…that is designed to distinguish between anticipatory and consummatory pleasure [25] and the Dimensional Anhedonia Rating Scale (DARS) is a 17-item self-report questionnaire and could re fl ect the anhedonia in different domains of hobbies, social activities, food/drink, and sensory experience [26].”
Dhami, P., Knyahnytska, Y., Atluri, S., Lee, J. C., Courtney, D., Croarkin, P. E., Blumberger, D. M., Daskalakis, Z. J., & Farzan, F. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.07.084 · Cited by 53
Patient-reported outcome measures for life engagement in mental health: a systematic review
McIntyre, R. S., Ismail, Z., Watling, C. P., Weiss, C., Meehan, S. R., Musingarimi, P., & Thase, M. E. (2022) · Journal of Patient-Reported Outcomes · doi:10.1186/s41687-022-00468-5 · Cited by 48
“37), and was able to distinguish MDD from healthy controls [49].”
BackgroundMethodInfluentialDhami, P., Atluri, S., Lee, J. C., Knyahnytska, Y., Croarkin, P. E., Blumberger, D. M., Daskalakis, Z. J., & Farzan, F. (2020) · Cerebral Cortex · doi:10.1093/cercor/bhaa004 · Cited by 53
“For the youth MDD group, Pearson correlations were assessed for TEPs and coherence measures with HRSD-17 and Dimensional Anhedonia Rating Scale (DARS) (Rizvi et al. 2015) scores.”
MethodInfluentialVigor, Effort-Related Aspects of Motivation and Anhedonia
Treadway, M. T., & Salamone, J. D. (2022) · Current topics in behavioral neurosciences · doi:10.1007/7854_2022_355 · Cited by 50
Unpacking Major Depressive Disorder: From Classification to Treatment Selection
Kennedy, S. H., & Ceniti, A. K. (2017) · The Canadian Journal of Psychiatry · doi:10.1177/0706743717748883 · Cited by 50
“The depth and sensitivity of these measures may allow for their utility in treatment selection; for instance, the DARS has demonstrated preliminary utility in distinguishing between treatment-resistant depression (TRD) and nonTRD subgroups.(39) The individual clinical features outlined above may have genetic and neura…”
BackgroundSelf-citationHallford, D. J., Rusanov, D., Yeow, J. J. E., Austin, D., D’Argembeau, A., Fuller‐Tyszkiewicz, M., & Raes, F. (2022) · Cognitive Therapy and Research · doi:10.1007/s10608-022-10330-z · Cited by 48
“…of anhedonia that tap into different domains, such as social activities, hobbies and sensory experiences (e.g., the Dimensional Anhedonia Rating Scale (Rizvi et al., 2015) or Snaith-Hamilton Pleasure Scale (Snaith et al., 1995), may be helpful to identify more precisely if where change occurs.”
BackgroundMethodWallace, C. J. K., Foster, J. A., Soares, C. N., & Milev, R. V. (2019) · Neuropsychobiology · doi:10.1159/000496406 · Cited by 50
Addressing anhedonia to increase depression treatment engagement
Khazanov, G. K., Forbes, C. N., Dunn, B. D., & Thase, M. E. (2021) · British Journal of Clinical Psychology · doi:10.1111/bjc.12335 · Cited by 48
Presentation and Neurobiology of Anhedonia in Mood Disorders: Commonalities and Distinctions
Rizvi, S. J., Lambert, C. M., & Kennedy, S. H. (2018) · Current Psychiatry Reports · doi:10.1007/s11920-018-0877-z · Cited by 49
Self-citationSantopetro, N. J., Brush, C. J., Burani, K., Bruchnak, A., & Hajcak, G. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.07.091 · Cited by 44
Pleasure, Reward Value, Prediction Error and Anhedonia
Kieslich, K., Valton, V., & Roiser, J. P. (2022) · Current topics in behavioral neurosciences · doi:10.1007/7854_2021_295 · Cited by 52
Fatt, C. C., Asbury, S., Jha, M. K., Minhajuddin, A., Sethuram, S., Mayes, T. L., Kennedy, S. H., Foster, J. A., & Trivedi, M. H. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02416-3 · Cited by 41
Self-citationTranslational Assessments of Reward and Anhedonia: A Tribute to Athina Markou
Der-Avakian, A., & Pizzagalli, D. A. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.02.008 · Cited by 36
“, Dimensional Anhedonia Rating Scale (17)], scales probe single domains of anhedonia (e.”
Wellan, S. A., Daniels, A., & Walter, H. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.682824 · Cited by 35
Dunlop, K., Grosenick, L., Downar, J. H., Vila‐Rodriguez, F., Gunning, F. M., Daskalakis, Z. J., Blumberger, D. M., & Liston, C. M. (2024) · Biological Psychiatry · doi:10.1016/j.biopsych.2024.01.012 · Cited by 36
Allen, T. A., Lam, R. W. M., Milev, R. V., Rizvi, S. J., Frey, B. N., MacQUEEN, G. M., Müller, D. J., Uher, R., Kennedy, S. H., & Quilty, L. C. (2018) · Psychological Medicine · doi:10.1017/s0033291718002441 · Cited by 35
“Dimensional anhedonia rating scale (DARS) The DARS (Rizvi et al., 2015) is a 17-item self-report scale that assesses variation in reward-related interest, motivation, effort, as well as consummatory pleasure.”
BackgroundSelf-citationKetamine rescues anhedonia by cell-type- and input-specific adaptations in the nucleus accumbens
Lucantonio, F., Roeglin, J., Li, S., Lu, J., Shi, A., Czerpaniak, K., Fiocchi, F. R., Bontempi, L., Shields, B. C., Zarate, C. A., et al. (2025) · Neuron · doi:10.1016/j.neuron.2025.02.021 · Cited by 33
“64 These findings suggest that even a single behavioral realm such as anhedonia may display multiple domains of impairments and that constructs generally associated with anhe-donia, such as fatigue, anergia, and avolition, may have unique neurobiological representations in the brain.”
Neurophysiological markers of response to theta burst stimulation in youth depression
Dhami, P., Atluri, S., Lee, J. C., Knyahnytska, Y., Croarkin, P. E., Blumberger, D. M., Daskalakis, Z. J., & Farzan, F. (2020) · Depression and Anxiety · doi:10.1002/da.23100 · Cited by 29
“In the youth MDD sample, we conducted Pearson's correlations between neurophysiological markers and Hamilton Rating Scale for Depression (HRSD‐17), Beck Depression Inventory (BDI), and Dimensional Anhedonia Rating Scale (DARS; Rizvi et al., 2015) scores.”
MethodInfluentialAssessing the relationship between the human learned helplessness depression model and anhedonia
Song, X., & Vilares, I. (2021) · PLoS ONE · doi:10.1371/journal.pone.0249056 · Cited by 32
“The three scales used in the experiment are the Beck Depression Inventory-II (BDI-II) [57], which includes an anhedonia subscale BDI-Anhedonic, the Fawcett-Clark Pleasure Capacity Scale (FCPS) [58], and the Dimensional Anhedonia Rating Scale (DARS) [59].”
MethodInfluentialWatson, R., McCabe, C., Harvey, K., & Reynolds, S. A. (2021) · Psychological Assessment · doi:10.1037/pas0000977 · Cited by 29
Fang, X., Zhan, G., Zhang, J., Xu, H., Zhu, B., Hu, Y., Yang, C., & Luo, A. (2019) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2019.17.2.189 · Cited by 27
Andersen, B. V., Chan, R. C. K., & Byrne, D. V. (2021) · Foods · doi:10.3390/foods10092044 · Cited by 28
“Scales applied in clinical research to assess anhedonia also focus on the sensory food experience, by addressing taste [14,15] or by referring to favourite foods [11,12,15], which points at the outermost relevance of sensory properties in the experience of pleasure.”
BackgroundMethodInfluentialKetamine treatment for anhedonia in unipolar and bipolar depression: a systematic review
Kwaśny, A., Kwaśna, J., Wilkowska, A., Szarmach, J., Słupski, J., Włodarczyk, A., & Cubała, W. J. (2024) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2024.04.014 · Cited by 27
Define and characterize the anhedonia in major depressive disorder: An explorative study
Lin, J., Su, Y., Rizvi, S. J., Jagoda, J., Li, J., Wu, Y., Dai, Y., Zhang, Y., Kennedy, S. H., & Si, T. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.06.082 · Cited by 26
Self-citationLinking anhedonia symptoms with behavioural and neural reward responses in adolescent depression
McCabe, C. (2018) · Current Opinion in Behavioral Sciences · doi:10.1016/j.cobeha.2018.07.001 · Cited by 26
“The Motivation and Pleasure scale, [26] the Anticipatory and Consummatory interpersonal pleasure scale (ACIPS) [27] and the Dimensional Anhedonia Rating Scale (DARS) [28] all attempt to separate components of reward processing, see here for review [16].”
Luc, O. T., Pizzagalli, D. A., & Kangas, B. D. (2021) · Perspectives on Behavior Science · doi:10.1007/s40614-021-00288-w · Cited by 25
Heise, M., Werthmann, J., Murphy, F. C., Tuschen‐Caffier, B., & Renner, F. (2022) · Cognitive Therapy and Research · doi:10.1007/s10608-022-10306-z · Cited by 28
“DARS: Dimensional Anhedonia Rating Scale (Rizvi et al., 2015).”
MethodInfluentialDercon, Q., Mehrhof, S. Z., Sandhu, T., Hitchcock, C., Lawson, R. P., Pizzagalli, D. A., Dalgleish, T., & Nord, C. L. (2023) · Psychological Medicine · doi:10.1017/s0033291723001587 · Cited by 32
Gao, K., Sweet, J. A., Su, M., & Calabrese, J. R. (2017) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2017.02.013 · Cited by 24
“Although, the lack of interest and pleasure are also highly correlated (Treadway and Zald, 2011, Thomsen, 2015(Rizvi et al., 2015), using QIDS-16-SR item 13 to measure the severity of anhedonia might have some impact on the overall outcomes.”
BackgroundSpanish adaptation of the Dimensional Anhedonia Rating Scale (DARS)
Arrua-Duarte, E., Migoya-Borja, M., Barrigón, M. L., Barahona, I., Delgado‐Gómez, D., Courtet, P., Aroca, F., Rizvi, S. J., Kennedy, S. H., Quilty, L. C., et al. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.11.040 · Cited by 23
Self-citationPreliminary Evidence of Efficacy and Target Engagement of Pramipexole in Anhedonic Depression
Ventorp, F., Lindahl, J., van Westen, D., Jensen, J., Björkstrand, J., & Lindqvist, D. (2022) · Psychiatric Research and Clinical Practice · doi:10.1176/appi.prcp.20210042 · Cited by 26
“The sample was enriched for significant anhedonia symptoms, enrolling only those patients with a score of <27 on the Dimensional Anhedonia Rating Scale (DARS, inverse scale) (7).”
MethodBibi, A., Margraf, J., & Blackwell, S. E. (2020) · Journal of Experimental Psychopathology · doi:10.1177/2043808720918030 · Cited by 26
“The DARS measures anhedonia across the following four areas: hobbies/pastimes, food/drink, social activities, and sensory experience (Rizvi et al., 2015).”
BackgroundPhillips, J. L., Jaworska, N., Kamler, E., Bhat, V., Blier, J., Foster, J. A., Hassel, S., Ho, K. T., McMurray, L., Milev, R. V., et al. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02672-3 · Cited by 24
“These include the Patient Health Questionnaire (PHQ-9) [34], Beck Scale for Suicide Ideation (BSS) [35], General Anxiety Disorder 7-item Scale (GAD-7) [36], Quality of Life, Enjoyment and Satisfaction Questionnaire - Short Form (Q-LESQ-SF) [37], Dimensional Anhedonia Rating Scale (DARS) [38], and Medical Outcome Study…”
MethodInfluentialSelf-citationDonegan, C. J., Daldegan‐Bueno, D., Sumner, R. L., Menkes, D. B., Evans, W., Hoeh, N. R., Sundram, F., Reynolds, L., Ponton, R., Cavadino, A., et al. (2023) · Pilot and Feasibility Studies · doi:10.1186/s40814-023-01399-8 · Cited by 21
“A nh e d o n i a s y m p t o m s D A R S [ 39 ] , a ss e ss e d a t b a s e l i n e a n d 8 ‑ w ee k t i m e p o i n t .”
Ketamine and esketamine for crisis management in patients with depression: Why, whom, and how?
Lengvenytė, A., Strumila, R., Olié, É., & Courtet, P. (2022) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2022.02.004 · Cited by 21
Poletti, M., Pelizza, L., Loas, G., Azzali, S., Paterlini, F., Garlassi, S., Scazza, I., Chiri, L. R., Pupo, S., & Raballo, A. (2023) · Psychiatry Research · doi:10.1016/j.psychres.2023.115177 · Cited by 21
“, 2014b) or the Dimensional Anhedonia Rating Scale (DARS) (Rizvi et al., 2015).”
Blackwell, S. E., Schönbrodt, F. D., Woud, M. L., Wannemüller, A., Bektas, B., Rodrigues, M. B., Hirdes, J., Stumpp, M. T., & Margraf, J. (2022) · Psychological Medicine · doi:10.1017/s0033291722003294 · Cited by 23
Bagheri, S., Taridashti, S., Farahani, H., Watson, P., & Rezvani, E. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1283095 · Cited by 25
Sullivan‐Toole, H., DePasque, S., Holt-Gosselin, B., & Galván, A. (2019) · Developmental Cognitive Neuroscience · doi:10.1016/j.dcn.2019.100652 · Cited by 21
Hyldelund, N. B., Byrne, D. V., & Andersen, B. V. (2022) · Foods · doi:10.3390/foods11050718 · Cited by 19
“Anhedonia, the lack of ability to perceive pleasure, is a common symptom of a wide range of diseases, including depression and schizophrenia [43,46,47].”
BackgroundHyldelund, N. B., Frederiksen, C., Byrne, D. V., & Andersen, B. V. (2022) · Foods · doi:10.3390/foods11131980 · Cited by 19
“Furthermore, the SHAPS has been translated into numerous languages, and has been validated as a precise and reliable measure of state anhedonia [38,46,47].”
MethodWackerhagen, C., Veer, I. M., van Leeuwen, J. M. C., Reppmann, Z. C., Riepenhausen, A., Bögemann, S. A., Mor, N., Puhlmann, L. M. C., Uściƚko, A., Zerban, M., et al. (2022) · JMIR Research Protocols · doi:10.2196/39817 · Cited by 19
“Multiple facets of hedonic function such as desire, motivation, effort, and consummatory pleasure across hedonic domains (17 items) [73].”
BackgroundBögemann, S. A., Riepenhausen, A., Puhlmann, L. M. C., Bar, S., Hermsen, E. J. C., Mituniewicz, J., Reppmann, Z. C., Uściƚko, A., van Leeuwen, J. M. C., Wackerhagen, C., et al. (2023) · BMC Psychology · doi:10.1186/s40359-023-01249-5 · Cited by 23
Daniels, A., Wellan, S. A., Beck, A., Erk, S., Wackerhagen, C., Romanczuk‐Seiferth, N., Schwarz, K., Schweiger, J. I., Meyer‐Lindenberg, A., Heinz, A., et al. (2025) · Cognitive Affective & Behavioral Neuroscience · doi:10.3758/s13415-024-01261-1 · Cited by 20
“Recent anhedonia scales, such as the Temporal Experience of Pleasure Scale (Gard et al., 2006), the Dimensional Anhedonia Rating Scale (Rizvi et al., 2015), or the recently developed Positive Valence Systems Scale (Khazanov et al., 2020), provide more comprehensive measures of anhedonia and its different subfacets for…”
Add-on probiotics for inflammatory depression – A double-blind randomized placebo-controlled trial
Veibäck, G. S., Lindahl, J., Suneson, K., Tjernberg, J., Ståhl, D., Landberg, R., Asp, M., Kjellberg, A., Falknäs, F., Sjöberg, K., et al. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.06.002 · Cited by 21
Carlton, C. N., Antezana, L., Garcia, K. M., Sullivan‐Toole, H., & Richey, J. A. (2021) · Affective Science · doi:10.1007/s42761-021-00085-3 · Cited by 15
“1 3 Dimensional Anhedonia Rating Scale (Rizvi et al., 2015) The Dimensional Anhedonia Rating Scale (DARS) is a 17-item questionnaire that assesses anhedonia severity across 4 domains: hobbies/past-times, food/drinks, social activities, and sensory experiences.”
BackgroundMethodInfluentialWestermann, K., Woud, M. L., Cwik, J. C., Graz, C., Nyhuis, P. W., Margraf, J., & Blackwell, S. E. (2021) · BJPsych Open · doi:10.1192/bjo.2021.1042 · Cited by 21
“Clinical outcome measures included: (a) an extended 26-item German version of the DARS, 15,22 a self-report measure of different facets of anhedonia (desire, motivation, effort and consummatory pleasure) across different hedonic domains (hobbies/ past-times, food/drinks, social activities and…”
MethodInfluentialMeyer, J. D., Perkins, S. L., Brower, C. S., Lansing, J. E., Slocum, J. A., Thomas, E. B. K., Murray, T. A., Lee, D.-C., & Wade, N. G. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.799600 · Cited by 16
Meyer, J. D., Murray, T. A., Brower, C. S., Cruz-Maldonado, G., Pérez, M., Ellingson, L. D., & Wade, N. G. (2022) · Psychology of sport and exercise · doi:10.1016/j.psychsport.2022.102172 · Cited by 17
Juarascio, A. S., Srivastava, P., Manasse, S. M., Wilkinson, M. L., Felonis, C. R., & Drexler, S. A. (2023) · International Journal of Eating Disorders · doi:10.1002/eat.23905 · Cited by 16
Clinical and Preclinical Assessments of Anhedonia in Psychiatric Disorders
Wang, S., Leri, F., & Rizvi, S. J. (2022) · Current topics in behavioral neurosciences · doi:10.1007/7854_2022_318 · Cited by 15
Self-citationBlackwell, S. E., Westermann, K., Woud, M. L., Cwik, J. C., Neher, T., Graz, C., Nyhuis, P. W., & Margraf, J. (2018) · Pilot and Feasibility Studies · doi:10.1186/s40814-018-0325-1 · Cited by 14
Lewis, L. R., Benn, A., Dwyer, D. M., & Robinson, E. S. J. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112051 · Cited by 15
Gorostowicz, A., Rizvi, S. J., Kennedy, S. H., Chrobak, A. A., Dudek, D., CYRANKA, K. M., Piekarska, J., Krawczyk, E., & Siwek, M. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1268290 · Cited by 13
“The DARS has also demonstrated additional utility over SHAPS in predicting treatment-resistance in a population of depressed patients (29).”
BackgroundMethodResultInfluentialSelf-citationEvaluating the item-level factor structure of anhedonia
Case, J. A. C., Sullivan‐Toole, H., Mattoni, M., Jacobucci, R., Forbes, E. E., & Olino, T. M. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.11.069 · Cited by 13
Vaccarino, S. R., Wang, S., Rizvi, S. J., Lou, W. Y. W., Hassel, S., MacQUEEN, G. M., Ho, K. T., Frey, B. N., Lam, R. W. M., Milev, R. V., et al. (2024) · BJPsych Open · doi:10.1192/bjo.2023.588 · Cited by 12
“4,5 In fact, anhedonia may be one of the most persistent symptoms of MDD, despite clinical remission from a major depressive episode (MDE): approximately 25% of individuals in remission continue to have residual symptoms of anhedonia.”
BackgroundSelf-citationCheng, C. P. W., Herr, K. J., Jeon, H. J., Kato, T., Ng, C. H., Yang, Y. K., & Zhang, L. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1338063 · Cited by 12
Rethorst, C. D., Hamann, H. A., Carmody, T. J., Sharp, K. J., Argenbright, K. E., Haley, B., Skinner, C. S., & Trivedi, M. H. (2018) · BMC Cancer · doi:10.1186/s12885-018-4662-5 · Cited by 14
Fan, H., Li, Q., Du, Y., Yan, Y., Ni, R., Wei, J., Zhao, L., Yang, X., & Ma, X. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1428425 · Cited by 13
Expression and role of microRNA-212/nuclear factor I-A in depressive mice
Si, L., Wang, Y., Liu, M., Yang, L., & Zhang, L. (2021) · Bioengineered · doi:10.1080/21655979.2021.2009964 · Cited by 11
“These manifestations might persist for prolonged periods or frequently recur in individuals experiencing depression, thereby severely affecting the individual’s ability to work, study, or perform dayto-day activities [2].”
BackgroundFood pleasure across nations: A comparison of the drivers between Chinese and Danish populations
Hyldelund, N. B., Byrne, D. V., Chan, R. C. K., & Andersen, B. V. (2021) · Food Quality and Preference · doi:10.1016/j.foodqual.2021.104493 · Cited by 11
Positive Affect Treatment for Depression and Anxiety
Craske, M. G., Dour, H. J., Treanor, M., & Meuret, A. E. (2022) · doi:10.1093/med-psych/9780197548523.001.0001 · Cited by 11
Antezana, L., Garcia, K. M., Carlton, C. N., Andino, M. V., Gatto, A. J., & Richey, J. A. (2024) · Journal of Psychopathology and Behavioral Assessment · doi:10.1007/s10862-024-10130-7 · Cited by 11
“A large body of literature has associated anhedonia with positive valence systems (Olino et al., 2018; Nusslock & Alloy, 2017; Pizzagalli, 2022), as it has important links to reward processes (Dillon et al., 2014; Rizvi et al., 2015, 2016).”
Terpstra, A. R., Vila‐Rodriguez, F., LeMoult, J., Chakrabarty, T., Nair, M. A., Humaira, A., Gregory, E., & Todd, R. M. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.10.041 · Cited by 9
“18) on the Dimensional Anhedonia Rating Scale (Rizvi et al., 2015), and hypomania symptoms (r = 0.”
BackgroundInfluentialKumar, D., Corner, S. E., Kim, R., & Meuret, A. E. (2024) · Behaviour Research and Therapy · doi:10.1016/j.brat.2024.104525 · Cited by 11
Validation of the Chinese Dimensional Anhedonia Rating Scale in Depressed Patients in Hong Kong
Ching, E. W.-K., Chiang, T. P., Wong, J. O. Y., Siu, B. W. M., Cheng, K. M., Lui, S. S. Y., & Cheung, E. F. C. (2021) · Psychological Test Adaptation and Development · doi:10.1027/2698-1866/a000012 · Cited by 9
Xiao, W., Zhu, R., Lv, Z., Fan, J., Yi, Z., Chen, J., Ju, K., & Yan, C. (2022) · PsyCh Journal · doi:10.1002/pchj.517 · Cited by 9
Bossarte, R. M., Kessler, R. C., Nierenberg, A. A., Chattopadhyay, A., Cuijpers, P. J., Enrique, Á., Foxworth, P. M., Gildea, S. M., Belnap, B. H., Haut, M. W., et al. (2022) · Trials · doi:10.1186/s13063-022-06438-y · Cited by 9
“Depression history and features Depression symptom severity [64, 89]; Melancholic features [90–92]; Mixed features [91, 93, 94]; Anhedonia [95, 96]; Atypical depression [64, 89, 90, 97], Endogenous depression [98–100]; History and persistence [98–100]; Suicidality [101–103]”
BackgroundDaniels, S., Horman, T., Lapointe, T., Melanson, B. A., Storace, A., Kennedy, S. H., Frey, B. N., Rizvi, S. J., Hassel, S., Müller, D. J., et al. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.11.108 · Cited by 11
Self-citationTreatment Differences in Primary and Specialty Settings in Veterans with Major Depression
Puac‐Polanco, V., Leung, L. B., Bossarte, R. M., Bryant, C., Keusch, J. N., Liu, H., Ziobrowski, H. N., Pigeon, W. R., Oslin, D. W., Post, E. P., et al. (2021) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2021.02.200475 · Cited by 8
Zapf, L., Kaster, T. S., Vila‐Rodriguez, F., Daskalakis, Z. J., Downar, J. H., & Blumberger, D. M. (2024) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-024-01929-2 · Cited by 8
LSD microdosing in major depressive disorder: results from an open-label trial
Daldegan‐Bueno, D., Donegan, C. J., Sumner, R. L., Forsyth, A., Evans, W., Alshakhouri, M., Reynolds, L., Ponton, R., Smith, T., Roop, P. S., et al. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110762 · Cited by 9
Positive Affect Treatment for Depression, Anxiety, and Low Positive Affect
Meuret, A. E., Rosenfield, D., Wang, E., Hough, C. M., Ritz, T., & Craske, M. G. (2026) · JAMA Network Open · doi:10.1001/jamanetworkopen.2026.7403 · Cited by 9
Rajeh, Y. N., Dolatshahi, B., Pourshahbaz, A., & Zarghami, M. (2022) · Iranian Journal of Psychiatry and Behavioral Sciences · doi:10.5812/ijpbs-120043 · Cited by 8
“According to Rizvi’s (5) study, DARS distinguished MDD vs.”
BackgroundMethodResultInfluentialLindahl, J., Asp, M., Ståhl, D., Tjernberg, J., Eklund, M., Björkstrand, J., van Westen, D., Jensen, J., Månsson, K. N. T., Tornberg, Å. B., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-076900 · Cited by 8
Andrews, P., Vega, J. N., Szymkowicz, S. M., NEWHOUSE, P. A., Tyndale, R. F., Elson, D. M., Kang, H., Siddiqi, S., Tyner, E. B., Mather, K., et al. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.07.025 · Cited by 8
Leonard, B. T., Kark, S. M., Granger, S. J., Adams, J. G., McMillan, L. C., & Yassa, M. A. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.08.113 · Cited by 8
“Additionally, specific tools designed to address anhedonia such as the Snaith-Hamilton Pleasure Scale (Snaith et al., 1995) or the Dimensional Anhedonia Rating Scale (Rizvi et al., 2015), were not used here, which necessitated the use of the latent factor approach.”
Chen, M., Lin, W.-C., Wu, H.-J., Bai, Y., Li, C., Tsai, S., Hong, C., Tu, P., & Su, T. (2021) · Psychopharmacology · doi:10.1007/s00213-020-05737-z · Cited by 8
Metadata
- Authors
- Rizvi, S. J., Quilty, L. C., Sproule, B. A., Cyriac, A., Michael Bagby, R., & Kennedy, S. H.
- Affiliations
- University Health Network (CA)
- Centre for Addiction and Mental Health (CA)
- St. Michael's Hospital (CA)
- Corresponding author
- Rizvi, Sakina J.
- Venue
- Psychiatry Research
- Publisher
- Elsevier BV
- Published
- 2015-09
- Volume
- 229
- Issue
- 1-2
- Pages
- 109-119
- ISSN
- 0165-1781 (ISSN-L)
- OpenAlex
- W1943465630
- Cited by
- 274
- References
- 52
- Citations by year
- 2026: 49 · 2025: 53 · 2024: 38 · 2023: 22 · 2022: 44 · 2021: 26 · 2020: 10 · 2019: 14 · 2018: 8 · 2017: 6 · 2016: 4
- FWCI
- 9.04
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Psychiatry Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ontario Problem Gambling Research Centre
- Department of Pharmaceutical Sciences, University of Toronto
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Mental Health Research Topics
- Keywords
- anhedonia, major depressive disorder, desire, motivation, effort, consummatory pleasure, reward function, scale development, scale validation, bipolar depression, Snaith-Hamilton Pleasure Scale, antidepressant non-response
- MeSH terms
- Adolescent, Adult, Cross-Sectional Studies, Major Depressive Disorder, Female, Humans, Male, Middle Aged, Motivation, Residence Characteristics, Reward, Reproducibility of Results, Young Adult, Pleasure, Self Report, Anhedonia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
